New shot could soothe stubborn hives when pills fail
NCT ID NCT07402213
First seen Feb 19, 2026 · Last updated May 15, 2026 · Updated 14 times
Summary
This study tests an experimental injection called JYB1904 for adults with chronic spontaneous urticaria (long-term hives and itching) that standard allergy pills don't fully control. About 180 participants will receive either the drug or a placebo to see if it reduces itching and hives over 12 weeks. The goal is to improve daily symptoms and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.